TrialAlimentary pharmacology & therapeutics2022

A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development.

Richard P Hermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.